Illumina, INC.
Ended Awarded Last action
- Contract number
- 75D30121F10365
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $0
Award facts
- Contract value 0% obligated
-
- $0.00 Current, with exercised options
- $11,400.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$11,400 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $11,400 |
About this award
Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call valued at $11,400 by the Centers for Disease Control and Prevention (CDC) Pittsburgh on January 27, 2021. The contract, with an ultimate completion date of February 15, 2021, was issued without a set-aside designation, reflecting Illumina's specialized position as a technology provider for sequencing systems and associated consumables. The work is to be performed at Illumina's San Diego facility, and this award represents a task order or call against an existing BPA vehicle, consistent with the company's standard federal procurement structure for its proprietary sequencing instruments, reagents, and related laboratory equipment.
This award exemplifies Illumina's extensive federal contracting presence across civilian agencies, particularly those requiring advanced genomic capabilities for research and diagnostic initiatives. The CDC's procurement aligns with the agency's mission to support disease surveillance, infectious disease research, and public health initiatives where next-generation sequencing technologies provide critical analytical capabilities. Illumina maintains substantial indefinite delivery vehicles and BPA agreements with multiple federal agencies, including a $45 million Indefinite Delivery Indefinite Quantity contract with the U.S. Department of Agriculture through June 2030, enabling rapid task order issuance for genomic sequencing solutions across federal research facilities and laboratories nationwide.
Quick answers
Who was awarded contract 75D30121F10365?
75D30121F10365 was awarded to Illumina, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on January 27, 2021.
How much is contract 75D30121F10365 worth?
The government has obligated $0 on 75D30121F10365. Its potential value, with all options, is $11,400.
Is contract 75D30121F10365 an order under another contract?
Yes. 75D30121F10365 is a BPA call under HHSD2002016M88745B, a blanket purchase agreement.
Was contract 75D30121F10365 competed?
The extent of competition for 75D30121F10365 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award